The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Crossref DOI link: https://doi.org/10.1186/s41124-016-0019-3
Published Online: 2016-09-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aleman, Soo https://orcid.org/0000-0003-0461-4870